13F reference period
Q3 2026
Security Snapshot
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) Institutional Ownership
CUSIP: 28658R106
13F Institutional Holders and Ownership History from Q3 2021 to Q3 2026
Institutions Reporting
56
Shares (Excl. Options)
12.29M
Full value: 12,292,385 · shares · 30 Sep 2026Price
$11.47
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- CLYM on Nasdaq
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 12,292,385
- Total 13F value
- $141,006,116
- Portfolio coverage rank
- 0%
- Share change
- +4,844,401
- Value change
- +$55,354,170
- Number of holders
- 56
- Shares outstanding
- 72,549,324
- SEC-reported price per share
- $10.83
- Insider filing price
- $10.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 28658R106.
- 56 institutions reported positions in Q3 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 108 to 56 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$734.34M
Full value: $734,336,724 · USD · 30 Jun 2026.$141.01M
Full value: $141,006,116 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 56 institutions filings for Q3 2026.
Security key
28658R106
13F reference period
Q3 2026
13F holders
56
13D/G owners
5
CIK / CUSIP context first
Open Q3 2026 holders
CLYM full holder history
Climb Bio, Inc. SEC filings
Climb Bio, Inc. company facts
Climb Bio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 28658R106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
CLYM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 33% | 0% | $259,284,030 | +$7,495,346 | 23,941,277 | +3% | RA Capital Management, L.P. | 05 Nov 2026 |
| FMR LLC | 15% | +26% | $93,305,129 | +$19,765,486 | 8,615,432 | +27% | FMR LLC | 30 Sep 2026 |
| Pontifax Management 4 G.P. (2015) Ltd. | 7.7% | $12,911,822 | 5,206,380 | Pontifax VI G.P. L.P. | 27 Jun 2024 | |||
| Flynn James E | 5.2% | $35,212,900 | 3,070,000 | Deerfield Mgmt, L.P. | 27 Oct 2026 | |||
| BlackRock, Inc. | 5% | $33,207,543 | 2,895,165 | BlackRock, Inc. | 30 Sep 2026 |
As of 30 Sep 2026,
56
institutional investors reported holding
shares of
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM).
This represents
17%
of the company’s total
outstanding shares.
12.29M
Full value: 12,292,385 · shares · 30 Sep 202672.55M
Full value: 72,549,324 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
16%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 2,375,933 | +40% | 0% | $27,251,952 |
| STATE STREET CORP | 2.6% | 1,850,010 | +169% | 0% | $21,219,615 |
| MORGAN STANLEY | 1.5% | 1,120,434 | +207% | 0% | $12,851,382 |
| Affinity Asset Advisors, LLC | 1.3% | 972,000 | 0% | 0.63% | $11,148,840 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 951,063 | +22% | 0% | $10,911,890 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1% | 730,000 | 0.12% | $8,373,100 | |
| MARSHALL WACE, LLP | 0.77% | 558,524 | 0.01% | $6,406,272 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.69% | 501,199 | +109% | 0% | $5,748,753 |
| DIMENSIONAL FUND ADVISORS LP | 0.55% | 401,549 | +68% | 0% | $4,605,912 |
| NAN FUNG TRINITY (HK) LTD | 0.5% | 360,654 | 0% | 0.4% | $4,136,701 |
| TD ASSET MANAGEMENT INC | 0.42% | 303,702 | +14% | 0% | $3,492,573 |
| Jefferies Financial Group Inc. | 0.4% | 290,850 | 0.04% | $3,336,050 | |
| VANGUARD FIDUCIARY TRUST CO | 0.4% | 287,299 | +47% | 0% | $3,295,320 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.25% | 181,463 | +10% | 0% | $2,081,381 |
| LPL Financial LLC | 0.22% | 157,202 | +207% | 0% | $1,803,107 |
| ArchPoint Investors | 0.18% | 132,900 | +3.1% | 0.32% | $1,524,363 |
| RAYMOND JAMES FINANCIAL INC | 0.18% | 130,178 | +416% | 0% | $1,493,142 |
| Qube Research & Technologies Ltd | 0.14% | 102,949 | -61% | 0% | $1,180,825 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.11% | 76,812 | 0% | $881,034 | |
| ALPS ADVISORS INC | 0.1% | 76,109 | +31% | 0% | $872,970 |
| AMERICAN CENTURY COMPANIES INC | 0.1% | 74,297 | +57% | 0% | $852,187 |
| RENAISSANCE TECHNOLOGIES LLC | 0.1% | 70,200 | -64% | 0% | $805,194 |
| Y-Intercept (Hong Kong) Ltd | 0.08% | 61,553 | 0.02% | $706,013 | |
| Rafferty Asset Management, LLC | 0.06% | 46,714 | 0% | $535,810 | |
| Fisher Asset Management, LLC | 0.06% | 43,996 | 0% | $504,634 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Headline period
Q3 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 12,292,385 | $141,006,116 | +$55,354,170 | $11.47 | 56 |
| 2026 Q2 | 56,328,574 | $734,336,724 | +$352,387,210 | $13.04 | 108 |
| 2026 Q1 | 32,289,057 | $221,168,507 | +$28,129,270 | $6.85 | 78 |
| 2025 Q4 | 28,744,224 | $114,993,449 | -$59,773,343 | $4.00 | 64 |
| 2025 Q3 | 44,576,107 | $89,598,934 | -$10,311,694 | $2.01 | 66 |
| 2025 Q2 | 49,893,947 | $61,871,600 | -$2,503,034 | $1.24 | 68 |
| 2025 Q1 | 51,939,064 | $63,368,269 | -$8,741,696 | $1.22 | 76 |
| 2024 Q4 | 55,706,408 | $100,272,719 | -$19,354,214 | $1.80 | 78 |
| 2024 Q3 | 54,655,767 | $278,130,509 | +$14,600,273 | $5.09 | 69 |
| 2024 Q2 | 49,901,732 | $354,801,793 | +$245,093,722 | $7.11 | 46 |
| 2024 Q1 | 16,855,387 | $46,194,788 | +$5,051 | $2.74 | 20 |
| 2023 Q4 | 16,853,724 | $45,505,627 | +$348,407 | $2.70 | 22 |
| 2023 Q3 | 16,728,590 | $43,997,383 | -$6,828 | $2.63 | 22 |
| 2023 Q2 | 16,730,361 | $46,844,345 | +$79,298 | $2.80 | 21 |
| 2023 Q1 | 16,702,070 | $48,434,001 | +$194,589 | $2.90 | 19 |
| 2022 Q4 | 16,628,134 | $61,000,699 | +$90,854 | $3.67 | 20 |
| 2022 Q3 | 14,807,225 | $47,821,510 | -$982,037 | $3.23 | 20 |
| 2022 Q2 | 15,127,218 | $45,689,000 | -$21,553,504 | $3.02 | 22 |
| 2022 Q1 | 17,488,772 | $146,733,000 | +$663,723 | $8.39 | 40 |
| 2021 Q4 | 17,373,074 | $181,720,000 | +$142,325 | $10.46 | 34 |
| 2021 Q3 | 17,279,112 | $310,677,000 | +$310,677,000 | $17.98 | 31 |